Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669148 · ClinicalTrials.gov registry record · NA
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 496
- Enrollment target
NCT01669148: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01669148 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 496 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01669148, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 496 participants
- Enrollment target
Study Summary
The primary hypothesis to be tested is: The detection of breast cancer will be increased with tomosynthesis (3D) imaging
Primary Outcome
Sensitivity is the number of true positives (TP) divided by the sum of TP and false negatives (FN): Sensitivity = TP / (TP+FN)
Interventions
- DEVICE Conventional
- DEVICE Tomosynthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 496 participants |
| Start Date | 2007-11 |
| Est. Completion | 2012-10 |
| Phase | NA |
What the finished NCT01669148 record still lists
NCT01669148 is an interventional study that assigns participants to a tested intervention. The registered 496 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which Conventional is the first listed.
NCT01669148 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01669148 about?
NCT01669148 is a clinical study titled "Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography". The primary hypothesis to be tested is: The detection of breast cancer will be increased with tomosynthesis (3D) imaging
What is the current status of trial NCT01669148?
This trial is currently completed. It is a NA study. The enrollment target is 496 participants. The study started on 2007-11. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01669148?
The interventions under investigation include: Conventional (DEVICE), Tomosynthesis (DEVICE).
Who is sponsoring clinical trial NCT01669148?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01669148's enrollment target sits among peer trials
496 213th of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
- NCT06778447 · 496 participants · NA
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
- NCT03175224 · 497 participants · Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia